These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 37850980)

  • 41. Evidence supports use of on-demand PrEP for HIV prevention.
    Chow EPF; Fairley CK
    Lancet HIV; 2022 Aug; 9(8):e524-e526. PubMed ID: 35772418
    [No Abstract]   [Full Text] [Related]  

  • 42. Australian gay men who have taken nonoccupational postexposure prophylaxis for HIV are in need of effective HIV prevention methods.
    Zablotska IB; Prestage G; Holt M; Poynten M; de Wit J; Guy R; Mao L; McAllister J; Grulich AE
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):424-8. PubMed ID: 21857349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.
    Martin JN; Roland ME; Neilands TB; Krone MR; Bamberger JD; Kohn RP; Chesney MA; Franses K; Kahn JO; Coates TJ; Katz MH
    AIDS; 2004 Mar; 18(5):787-92. PubMed ID: 15075514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute HIV at the Time of Initiation of Pre-exposure or Post-exposure Prophylaxis: Impact on Drug Resistance and Clinical Outcomes.
    Johnson KA; Chen MJ; Kohn R; Sachdev D; Bacon O; Lee S; Cohen SE
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):818-825. PubMed ID: 33512849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users.
    Grace D; Jollimore J; MacPherson P; Strang MJP; Tan DHS
    AIDS Patient Care STDS; 2018 Jan; 32(1):24-30. PubMed ID: 29185801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What Community-Based HIV Prevention Organizations Say About Their Role in Biomedical HIV Prevention.
    Smith DK; Maier E; Betts J; Gray S; Kolodziejski B; Hoover KW
    AIDS Educ Prev; 2016 Oct; 28(5):426-439. PubMed ID: 27710082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda.
    Baggaley R; Doherty M; Ball A; Ford N; Hirnschall G
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S159-60. PubMed ID: 25972496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postexposure prophylaxis: an intervention to prevent human immunodeficiency virus infection in adolescents.
    Olshen E; Samples CL
    Curr Opin Pediatr; 2003 Aug; 15(4):379-84. PubMed ID: 12891049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. News from CROI 2022 - caveats using antiretrovirals as HIV prophylaxis.
    Barreiro P; Soriano V
    AIDS Rev; 2022 Apr; 24(2):98-99. PubMed ID: 35544744
    [No Abstract]   [Full Text] [Related]  

  • 50. Awareness and use of pre-exposure and postexposure prophylaxes among Nigerian university students: Findings from a cross-sectional survey.
    Ajayi AI; Ismail KO; Adeniyi OV; Akpan W
    Medicine (Baltimore); 2018 Sep; 97(36):e12226. PubMed ID: 30200145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
    Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
    Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prioritising the values of potential users to promote uptake of HIV pre-exposure prophylaxis.
    Traeger MW; Krakower DS; Mayer KH; Marcus JL
    Lancet HIV; 2023 Oct; 10(10):e690-e692. PubMed ID: 37573870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Barriers to HIV pre-exposure prophylaxis among African, Caribbean and Black men in Toronto, Canada.
    Zhabokritsky A; Nelson LE; Tharao W; Husbands W; Sa T; Zhang N; Thomas-Pavanel J; Baidoobonso S; Kaul R
    PLoS One; 2019; 14(3):e0213740. PubMed ID: 30925582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review.
    Elliott T; Sanders EJ; Doherty M; Ndung'u T; Cohen M; Patel P; Cairns G; Rutstein SE; Ananworanich J; Brown C; Fidler S
    J Int AIDS Soc; 2019 Dec; 22(12):e25419. PubMed ID: 31850686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.
    Mboup A; Béhanzin L; Guédou FA; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Geidelberg L; Cianci F; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Boily MC; Vickerman P; Alary M
    J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transitioning from HIV post-exposure prophylaxis to pre-exposure prophylaxis in men who have sex with men.
    Richardson D; Nichols K; Pickering A; Devlin J; Buss Z; Fitzpatrick C; Cresswell F
    HIV Med; 2021 Sep; 22(8):780-781. PubMed ID: 33930241
    [No Abstract]   [Full Text] [Related]  

  • 58. Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool.
    Reyniers T; Hoornenborg E; Vuylsteke B; Wouters K; Laga M
    Sex Transm Infect; 2017 Aug; 93(5):363-367. PubMed ID: 27872326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.
    Laurent C; Dembélé Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traoré I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fayé-Ketté H; Koné A; Diandé S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B;
    Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention in South Africa: Is There a Will and a Way?
    Landovitz RJ; Grinsztejn B
    J Infect Dis; 2016 May; 213(10):1519-20. PubMed ID: 26681779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.